Work

Evolution of FMT – From early clinical to standardized treatments

Year: 2022

Type: article

Source: Biologicals

DOI: 10.1016/j.biologicals.2022.01.004

Authors: Stephanie L. Servetas, Phillip J. Daschner, Cyril Guyard, Vincent Thomas, Herve Affagard, Chrysi Sergaki, Harry Sokol, Jennifer A. Wargo, Gary D. Wu, Philippe Sabot

Institutions: National Institute of Standards and Technology, National Institutes of Health, National Cancer Institute, BIOASTER, MaaT Pharma (France), National Institute for Biological Standards and Control, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, The University of Texas MD Anderson Cancer Center, University of Pennsylvania, International Alliance for Biological Standardization

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206983020

FWCI: 0.907

Cites: 19

Cited by: 11

Related to: 10